Kristen M. Ludgate - 08 Dec 2022 Form 4 Insider Report for HP INC (HPQ)

Signature
/s/ Rick Hansen as Attorney-in-Fact for Kristen Ludgate
Issuer symbol
HPQ
Transactions as of
08 Dec 2022
Net transactions value
$0
Form type
4
Filing time
12 Dec 2022, 19:18:31 UTC
Previous filing
09 Dec 2022
Next filing
14 Jul 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HPQ Restricted Stock Units Award +47,191 47,191 08 Dec 2022 Common Stock 47,191 Direct F1, F2
transaction HPQ Performance Adjusted Restricted Stock Units Award +30,191 30,191 08 Dec 2022 Common Stock 30,191 Direct F3, F4
transaction HPQ Performance Contingent Stock Options Award +106,864 106,864 08 Dec 2022 Common Stock 106,864 $28.48 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F2 On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
F3 Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.
F4 On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
F5 On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.